Results 31 to 40 of about 11,884 (322)

Sugammadex administration in patients with end-stage renal disease: a narrative review with recommendations

open access: yesAnesthesia and Pain Medicine, 2023
Due to unknown safety concerns, sugammadex should not be administered to patients with end-stage renal disease (ESRD). However, because the supply of benzylisoquinolinium-type neuromuscular blocking agents (NMBAs) has been discontinued, rocuronium is the
S. Oh, B. Lim
semanticscholar   +1 more source

Rocuronium-sugammadex use for electroconvulsive therapy in a hemodialysis patient: a case report

open access: yesJA Clinical Reports, 2016
Background Recently, rocuronium with subsequent use of sugammadex was proposed for electroconvulsive therapy (ECT) as an alternative to succinylcholine.
Shigeaki Kurita   +5 more
doaj   +1 more source

Reversal of rocuronium‐induced intense neuromuscular blockade by sugammadex in Korean children: A pharmacokinetic and pharmacodynamic analysis

open access: yesClinical and Translational Science, 2023
Sugammadex, a selective antagonist of steroidal non‐depolarizing neuromuscular blocking agents, has been used in children in limited circumstances. However, neither pharmacokinetics (PKs) nor recovery profile of sugammadex for intense neuromuscular ...
Sang‐Hwan Ji   +8 more
doaj   +1 more source

In the hour of Sugammadex [PDF]

open access: yesKorean Journal of Anesthesiology, 2013
Sugammadex is a modified gamma-cyclodextrin which is showing favorable outcomes regarding reversal of neuromuscular blockade, especially by rocuronium. It is designed to encapsulate rocuronium and being considered a new class of drugs as selective relaxant binding agents.
openaire   +3 more sources

Profile of sugammadex for reversal of neuromuscular blockade in the elderly: Current perspectives [PDF]

open access: yes, 2017
The number of elderly patients is increasing worldwide. This will have a significant impact on the practice of anesthesia in future decades. Anesthesiologists must provide care for an increasing number of elderly patients, who have an elevated risk of ...
Bertoncello, Francesco   +2 more
core   +1 more source

The Impact of Rocuronium and Sugammadex on Length of Stay in Patients Undergoing Open Spine Surgery: A Propensity Score-Matched Analysis

open access: yesBioengineering, 2023
Enhanced Recovery After Surgery (ERAS), an all-encompassing perioperative care approach, has been demonstrated to enhance surgical results, mitigate postoperative issues, and decrease the length of hospital stay (LOS) in diverse surgical specialties.
E. Wu   +7 more
semanticscholar   +1 more source

Sugammadex

open access: yesCritical Care and Resuscitation, 2013
Sugammadex is the first selective antagonist to reverse neuromuscular blockade induced by rocuronium and vecuronium. The mechanism by which sugammadex works is superior to current neuromuscular block reversal strategies in terms of speed, efficacy and side effects.
Dharshi, Karalapillai   +2 more
openaire   +2 more sources

Neuromuscular Blockade with Rocuronium Bromide Increases the Tolerance of Acute Normovolemic Anemia in Anesthetized Pigs [PDF]

open access: yes, 2012
Background: The patient's individual anemia tolerance is pivotal when blood transfusions become necessary, but are not feasible for some reason. To date, the effects of neuromuscular blockade (NMB) on anemia tolerance have not been investigated. Methods:
A. Pape   +46 more
core   +1 more source

Dual effects of leptin in perioperative gas exchange of morbidly obese patients [PDF]

open access: yes, 2018
Leptin has shown positive effects on respiratory function in experimental settings. The role of leptin on perioperative respiratory function in morbidly obese patients has not been established.
Carron, Michele   +6 more
core   +2 more sources

Home - About - Disclaimer - Privacy